Zydus Lifesciences Appoints Christoph Stoller as Head of International Markets
Zydus Lifesciences Ltd 路 Change in Management 路 01 Nov 2026, 1:01 am
Zydus Lifesciences Appoints Christoph Stoller as Head of International Markets Zydus Lifesciences announced that Dr. Amrut Naik resigned as President and Business Unit Head, International Markets Business on 31st Oct'26, effective 7th Nov'26. The Board approved the appointment of Christoph Stoller as his successor effective 2nd Nov'26. Stoller brings over 30 years of global pharmaceutical experience, previously managing >USD 750 million P&L at Glenmark across EMEA, LATAM, and APAC, and holding senior leadership roles at Teva Pharmaceuticals with up to USD 2 billion P&L oversight.
Original exchange filing (PDF)
More announcements from Zydus Lifesciences Ltd
- Press Release 路 14 Nov 2026
- Completion of transaction 路 12 Nov 2026
- Transcript of the post results earnings call held on November 4, 2026. 路 07 Nov 2026
- Press Release 路 07 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India 路 06 Nov 2026
- Investor Conference 路 06 Nov 2026
- Audio recording of the Company's Investor Call 路 05 Nov 2026
- Press Release 路 04 Nov 2026
